Maligne Lymphome

  • Peter Kaudewitz
  • Christian Sander
Conference paper
Part of the Fortschritte der praktischen Dermatologie und Venerologie book series (DERMATOLOGIE, volume 14)

Zusammenfassung

Einzelne Formen der malignen kutanen Lymphome, wie die Mycosis fungoides, gehören zu den ältesten Entitäten unseres Fachgebietes und haben ihre Defi nition ganz überwiegend in einem charakteristi schen klinischen Erscheinungsbild. Selten ist aber in der Praxis eine Blickdiagnose mit ausreichender Si cherheit zu stellen. Sie muß durch ergänzende Un tersuchungen erhärtet werden. Die dann anlaufende Diagnostik maligner Lymphome liefert Befunde, die vom Hautarzt interpretiert und seinem Patienten verständlich gemacht werden müssen. Die Befunde basieren methodisch auf den Ergebnissen der klini schen und immunologischen Forschung und sind damit das Medium, über das der Wandel innerhalb der Krankheitsgruppe maligne Lymphome für den Dermatologen in der Praxis unmittelbar erlebbar wird. Es erscheint daher sinnvoll, die wesentlichen diagnostischen Methoden und ihre Bedeutung für das gewandelte Verständnis maligner Lymphome der Haut zu erörtern.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Borowitz MJ, Weidner A, Olsen EA, Picker LJ (1993) Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: cutaneous lymphocyte-associatet antigen expression on T cells correlates with extend of disease. Leukemia 7:859–863.PubMedGoogle Scholar
  2. 2.
    Burg G, Zwingers T, Staegemeir E, Santucci M, EORTC — Cutaneous Lymphoma Project Group (1994) Interrater and intrarater variabilities in the evaluation of cu taneous lymphoproliferative T-cell infiltrates. Dermatol Clin 12:311–314.PubMedGoogle Scholar
  3. 3.
    Clark JR, Williams ME, Swerdlow SH (1990) Detection of B-and T-cells in paraffine embedded tissue sec tions. Diagnostic utility of commercially obtained 4KB5 and UCHL-1. Am J Clin Pathol 93:58–69.Google Scholar
  4. 4.
    Cooper KD (1992) Skin-infiltrating lymphocytes in normal and disordered skin: activation signals and functional roles in psoriasis and mycosis fungoidestype cutaneous T cell lymphoma. J Dermatol 19:731–737.PubMedCrossRefGoogle Scholar
  5. 5.
    Fraser IF (1925) Mycosis fungoides: its relation to leu kemia and lymphosarkoma. Arch Dermatol Syphil 12:814–828.CrossRefGoogle Scholar
  6. 6.
    Garbe C, Stein H, Dienemann D, Orfanos CE (1991) Borrelia burgdorferi associated cutaneous B cell lym phoma: clinical and immunohistological characterisa tion of four cases. J Am Acad Dermatol 24:584–590.PubMedCrossRefGoogle Scholar
  7. 7.
    Hammar E, Sangueza 0, Suwanjindar P, White CR, Braziel RM (1993) Immunophenotypic and genotypic analysis in cutaneous lymphoid hyperplasia. J Am Acad Dermatol 28:426–433.CrossRefGoogle Scholar
  8. 8.
    Harris LH, Jaffe SE, Stein H et al. (1994) A revised Eu ropean-American classification of lymphoid neo plasms: a proposal from the international lymphoma study group. Blood 84:1361–1392.PubMedGoogle Scholar
  9. 9.
    Hauschild A, Sterry W (1989) Formalin-resistant leu kocyte surface antigens in the diagnosis of cutaneous malignant lymphomas. Am J Pathol 135:177–184.PubMedCentralPubMedGoogle Scholar
  10. 10.
    Ho VC, Baadsgaard O, Elder TJ et al. (1990) Genotypic analysis of T-cell clones derived from cutaneous T-cell lymphoma lesions demonstrates selective growth of tu mor infiltrating lymphocytes. J Invest Dermatol 95:4–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Lessin RS, Rook A, Rovera G (1991) Molecular diagno sis of cutaneous T-cell lymphoma: polymerase chain reaction amplification of T-cell antigen receptor β-chain gene rearrangements. J Invest Dermatol 96:299–302.PubMedCrossRefGoogle Scholar
  12. 12.
    Olerud JE, Kulin PA, Chew ED et al. (1992) Cutaneous T-cell lymphoma. Evaluation of pretreatment skin biopsy specimens by a panel of pathologists. Arch Dermatol 128:501–507.Google Scholar
  13. 13.
    Picker LJ, Weiß LM, Medeiros LJ, Wood GS, Warnke R (1987) Immunophenotypic criteria for the diagnosis of non-Hodgkin’s lymphoma. Am J Pathol 128:181–201.PubMedCentralPubMedGoogle Scholar
  14. 14.
    Preesman AH, Hu HZ, Tilanus MGJ et al. (1992) T-cell receptor Vβ-family usage in primary cutaneous and primary nodal non-Hodgkin’s lymphoma. J Invest Dermatol 99:587–593.PubMedCrossRefGoogle Scholar
  15. 15.
    Saed G, Fivenson DO, Naidu Y, Nickoloff BJ (1994) My cosis fungoides exhibits a Th1-type cell mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile. J Invest Dermatol 103:29–33.PubMedCrossRefGoogle Scholar
  16. 16.
    Santucci M, Burg G, Feller AC (1994) Interrater and intrarater reliability of histologic criteria in early cutane ous T-cell lymphoma. Dermatol Clin 12:323–327.PubMedCrossRefGoogle Scholar
  17. 17.
    Stein H, Dallenbach F, Dienemann D (1988) Differen zierungslinien physiologischer und maligner Zellen des lymphatischen Systems. Verh Dtsch Ges Pathol 72:57–85.PubMedGoogle Scholar
  18. 18.
    Sterry W, Mielke V (1989) CD4 + cutaneous T-cell lymphomas show the phenotype of helper/inducer cells (CD45RA+, CDw29 +). J Invest Dermatol 93:413–416.PubMedCrossRefGoogle Scholar
  19. 19.
    Volkenandt M, Wienicke R, Koch OM (1993) Conformational polymorphism of cRNA of T-cell receptor genes as a clone specific molecular marker for cutane ous lymphoma. J Invest Dermatol 101:514–516.PubMedCrossRefGoogle Scholar
  20. 20.
    Weinberg JM, Rook AH, Lessin SR (1993) Molecular diagnosis of lymphocytic infiltrates of the skin. Arch Dermatol 129:1491–1500.PubMedCrossRefGoogle Scholar
  21. 21.
    Wood GS, Tung M, Haeffner AC et al. (1994) Detection of clonal T-cell receptor y gene rearrangements in ear ly mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol 103:34–41.PubMedCrossRefGoogle Scholar
  22. 22.
    Zucker-Franklin D, Hooper WC, Evatt BL (1992) Hu man lymphotropic retroviruses associated with myco sis fungoides: evidence that human T-cell lymphotro pic virus type II (HTLV-II) as well as HTLV-I may play a role in the disease. Blood 80:1537–1545.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • Peter Kaudewitz
  • Christian Sander

There are no affiliations available

Personalised recommendations